Byotrol Plc
("Byotrol" or the
"Company")
Director
Dealing
Byotrol Plc (AIM: BYOT), the
specialist infection prevention and control company, announces
that, on 2nd April 2024, David Traynor, Interim CEO of
the Company, purchased a total of 2,808,326 ordinary shares of
0.25p each ("Ordinary Shares") at an average price of 0.134p per
Ordinary Share (the "Purchase").
Following the Purchase, Mr.
Traynor's beneficial holding is 12,743,623 Ordinary Shares,
representing 2.8% of the total voting rights of the Company. As
announced on 28 July 2022, Mr. Traynor subscribed for convertible
loan notes in the Company, which if converted would represent an
additional 0.34% of the total voting rights of the
Company.
For
further information contact:
Byotrol Plc
|
|
Dr Trevor Francis, Non- Executive
Chairman
|
+44
(0)1925 742 000
|
David Traynor, Interim Chief
Executive Officer
Chris Sedwell, Chief Financial
Officer
|
|
|
|
Cavendish Capital Markets Limited (Nominated Adviser and
Broker)
|
+44 (0)20
7220 0500
|
Geoff Nash/George Dollemore -
Corporate Finance
Nigel Birks/Harriet Ward -
ECM
|
|
|
|
|
|
Flagstaff Strategic and Investor
Communications
|
+44 (0)20
7129 1474
|
Tim Thompson/Andrea Seymour/Fergus
Mellon
|
byotrol@flagstaffcomms.com
|
The information communicated in this announcement contains
inside information for the purposes of Article 7 of the Market
Abuse Regulation (EU) No. 596/2014.
Notes to
editors
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection
prevention and control company, operating globally in the animal
and human healthare, industrial, institutional and consumer
sectors, providing low toxicity products with a broad-based and
targeted efficacy across all microbial classes; bacteria, viruses
(including coronavirus), fungi, moulds, mycobacteria and
algae.
Byotrol's products can be used stand-alone or as ingredients
within existing products, where they can significantly improve
their performance, especially in personal hygiene, domestic and
industrial disinfection, odour control, food production and food
management.
Byotrol develops and commercialises technologies that create
easier, safer and cleaner lives for everyone.
For more information, go to byotrol.com
The Notification of Dealing Form set
out below is provided in accordance with the requirements of the EU
Market Abuse Regulation.
1.
|
Details of the person discharging
managerial responsibilities / person closely associated
|
a)
|
Name
|
David Traynor
|
2.
|
Reason for the
Notification
|
a)
|
Position/status
|
Interim Chief Executive
Officer
|
b)
|
Initial
notification/Amendment
|
Initial Notification
|
3.
|
Details of the issuer, emission
allowance market participant, auction platform, auctioneer or
auction monitor
|
a)
|
Name
|
Byotrol plc
|
b)
|
LEI
|
213800AJMTSTIPA59A34
|
4.
|
Details of the transaction(s):
section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date; and (iv) each place where
transactions have been conducted
|
a)
|
Description of the Financial
instrument, type of instrument
|
Ordinary shares of 0.25 pence per
share
|
Identification code
|
GB00B0999995
|
b)
|
Nature of the transaction
|
Purchase of Ordinary
Shares
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
0.134p
|
2,808,326
|
|
d)
|
Aggregated information:
·Aggregated
volume
· Price
|
See 4c) above
|
e)
|
Date of the transaction
|
2 April 2024
|
f)
|
Place of the transaction
|
AIM, London Stock Exchange
(XLON)
|